Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Role of SUMOylation in differential ERα transcriptional repression by tamoxifen and fulvestrant in breast cancer cells.

Traboulsi T, El Ezzy M, Dumeaux V, Audemard E, Mader S.

Oncogene. 2018 Sep 6. doi: 10.1038/s41388-018-0468-9. [Epub ahead of print]

PMID:
30190545
2.

Interactions between the tumor and the blood systemic response of breast cancer patients.

Dumeaux V, Fjukstad B, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Børresen-Dale AL, Bongo LA, Lund E, Hallett M.

PLoS Comput Biol. 2017 Sep 28;13(9):e1005680. doi: 10.1371/journal.pcbi.1005680. eCollection 2017 Sep.

3.

Erratum to: Detecting gene signature activation in breast cancer in an absolute, single-patient manner.

Paquet ER, Lesurf R, Tofigh A, Dumeaux V, Hallett MT.

Breast Cancer Res. 2017 Apr 13;19(1):48. doi: 10.1186/s13058-017-0842-5. No abstract available.

4.

Detecting gene signature activation in breast cancer in an absolute, single-patient manner.

Paquet ER, Lesurf R, Tofigh A, Dumeaux V, Hallett MT.

Breast Cancer Res. 2017 Mar 21;19(1):32. doi: 10.1186/s13058-017-0824-7. Erratum in: Breast Cancer Res. 2017 Apr 13;19(1):48.

5.

The prognostic ease and difficulty of invasive breast carcinoma.

Tofigh A, Suderman M, Paquet ER, Livingstone J, Bertos N, Saleh SM, Zhao H, Souleimanova M, Cory S, Lesurf R, Shahalizadeh S, Garcia Lopez N, Riazalhosseini Y, Omeroglu A, Ursini-Siegel J, Park M, Dumeaux V, Hallett M.

Cell Rep. 2014 Oct 9;9(1):129-142. doi: 10.1016/j.celrep.2014.08.073. Epub 2014 Oct 2.

6.

Peripheral blood cells inform on the presence of breast cancer: a population-based case-control study.

Dumeaux V, Ursini-Siegel J, Flatberg A, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Lund E.

Int J Cancer. 2015 Feb 1;136(3):656-67. doi: 10.1002/ijc.29030. Epub 2014 Jun 25.

7.

High coffee consumption and different brewing methods in relation to postmenopausal endometrial cancer risk in the Norwegian women and cancer study: a population-based prospective study.

Gavrilyuk O, Braaten T, Skeie G, Weiderpass E, Dumeaux V, Lund E.

BMC Womens Health. 2014 Mar 25;14:48. doi: 10.1186/1472-6874-14-48.

8.

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.

Ritte R, Tikk K, Lukanova A, Tjønneland A, Olsen A, Overvad K, Dossus L, Fournier A, Clavel-Chapelon F, Grote V, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Berrino F, Mattiello A, Tumino R, Sacerdote C, Quirós JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Wareham N, Khaw KT, Key TJ, Travis RC, Weiderpass E, Dumeaux V, Lund E, Sund M, Andersson A, Romieu I, Rinaldi S, Vineis P, Merritt MA, Riboli E, Kaaks R.

BMC Cancer. 2013 Dec 9;13:584. doi: 10.1186/1471-2407-13-584.

9.

Genome-wide association study in breast cancer survivors reveals SNPs associated with gene expression of genes belonging to MHC class I and II.

Landmark-Høyvik H, Dumeaux V, Nebdal D, Lund E, Tost J, Kamatani Y, Renault V, Børresen-Dale AL, Kristensen V, Edvardsen H.

Genomics. 2013 Oct;102(4):278-87. doi: 10.1016/j.ygeno.2013.07.006. Epub 2013 Jul 21.

10.

Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.

González CA, Megraud F, Buissonniere A, Lujan Barroso L, Agudo A, Duell EJ, Boutron-Ruault MC, Clavel-Chapelon F, Palli D, Krogh V, Mattiello A, Tumino R, Sacerdote C, Quirós JR, Sanchez-Cantalejo E, Navarro C, Barricarte A, Dorronsoro M, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Bas Bueno-de-Mesquita H, Jeurnink SM, Numans ME, Peeters PH, Lagiou P, Valanou E, Trichopoulou A, Kaaks R, Lukanova-McGregor A, Bergman MM, Boeing H, Manjer J, Lindkvist B, Stenling R, Hallmans G, Mortensen LM, Overvad K, Olsen A, Tjonneland A, Bakken K, Dumeaux V, Lund E, Jenab M, Romieu I, Michaud D, Mouw T, Carneiro F, Fenge C, Riboli E.

Ann Oncol. 2012 May;23(5):1320-4. doi: 10.1093/annonc/mdr384. Epub 2011 Sep 14.

PMID:
21917738
11.

Using blood gene signatures for assessing effects of exposure to perfluoroalkyl acids (PFAAs) in humans: the NOWAC postgenome study.

Rylander C, Dumeaux V, Olsen KS, Waaseth M, Sandanger TM, Lund E.

Int J Mol Epidemiol Genet. 2011 Aug 30;2(3):207-16. Epub 2011 Jun 3.

12.

Sex hormones and gene expression signatures in peripheral blood from postmenopausal women - the NOWAC postgenome study.

Waaseth M, Olsen KS, Rylander C, Lund E, Dumeaux V.

BMC Med Genomics. 2011 Mar 31;4:29. doi: 10.1186/1755-8794-4-29.

13.

Blood gene expression profiling of breast cancer survivors experiencing fibrosis.

Landmark-Høyvik H, Dumeaux V, Reinertsen KV, Edvardsen H, Fosså SD, Børresen-Dale AL.

Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):875-83. doi: 10.1016/j.ijrobp.2010.09.052. Epub 2010 Dec 2.

PMID:
21129856
14.

Cigarette smoking and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study.

Leufkens AM, Van Duijnhoven FJ, Siersema PD, Boshuizen HC, Vrieling A, Agudo A, Gram IT, Weiderpass E, Dahm C, Overvad K, Tjønneland A, Olsen A, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Palli D, Grioni S, Tumino R, Sacerdote C, Mattiello A, Herman S, Kaaks R, Steffen A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, van Gils CH, van Kranen H, Lund E, Dumeaux V, Engeset D, Rodríguez L, Sánchez MJ, Chirlaque MD, Barricarte A, Manjer J, Almquist M, van Guelpen B, Hallmans G, Khaw KT, Wareham N, Tsilidis KK, Straif K, Leon-Roux M, Vineis P, Norat T, Riboli E, Bueno-de-Mesquita HB.

Clin Gastroenterol Hepatol. 2011 Feb;9(2):137-44. doi: 10.1016/j.cgh.2010.10.012. Epub 2010 Oct 26.

PMID:
21029790
15.

Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.

Gu F, Schumacher FR, Canzian F, Allen NE, Albanes D, Berg CD, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Buring JE, Chabbert-Buffet N, Chanock SJ, Clavel-Chapelon F, Dumeaux V, Gaziano JM, Giovannucci EL, Haiman CA, Hankinson SE, Hayes RB, Henderson BE, Hunter DJ, Hoover RN, Johansson M, Key TJ, Khaw KT, Kolonel LN, Lagiou P, Lee IM, LeMarchand L, Lund E, Ma J, Onland-Moret NC, Overvad K, Rodriguez L, Sacerdote C, Sánchez MJ, Stampfer MJ, Stattin P, Stram DO, Thomas G, Thun MJ, Tjønneland A, Trichopoulos D, Tumino R, Virtamo J, Weinstein SJ, Willett WC, Yeager M, Zhang SM, Kaaks R, Riboli E, Ziegler RG, Kraft P.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2877-87. doi: 10.1158/1055-9965.EPI-10-0507. Epub 2010 Sep 1.

16.

The genetics and epigenetics of fatigue.

Landmark-Høyvik H, Reinertsen KV, Loge JH, Kristensen VN, Dumeaux V, Fosså SD, Børresen-Dale AL, Edvardsen H.

PM R. 2010 May;2(5):456-65. doi: 10.1016/j.pmrj.2010.04.003. Review.

PMID:
20656628
17.

Deciphering normal blood gene expression variation--The NOWAC postgenome study.

Dumeaux V, Olsen KS, Nuel G, Paulssen RH, Børresen-Dale AL, Lund E.

PLoS Genet. 2010 Mar 12;6(3):e1000873. doi: 10.1371/journal.pgen.1000873.

18.

Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.

Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, Fabre A, Hémon B, Rinaldi S, Chajes V, Slimani N, Allen NE, Reeves GK, Bingham S, Khaw KT, Olsen A, Tjønneland A, Rodriguez L, Sánchez MJ, Etxezarreta PA, Ardanaz E, Tormo MJ, Peeters PH, van Gils CH, Steffen A, Schulz M, Chang-Claude J, Kaaks R, Tumino R, Gallo V, Norat T, Riboli E, Panico S, Masala G, González CA, Berrino F.

Int J Cancer. 2011 Jan 1;128(1):144-56. doi: 10.1002/ijc.25314.

19.

Gene expression profiling of peripheral blood cells for early detection of breast cancer.

Aarøe J, Lindahl T, Dumeaux V, Saebø S, Tobin D, Hagen N, Skaane P, Lönneborg A, Sharma P, Børresen-Dale AL.

Breast Cancer Res. 2010;12(1):R7. doi: 10.1186/bcr2472. Epub 2010 Jan 15.

20.

Polymorphisms in fatty-acid-metabolism-related genes are associated with colorectal cancer risk.

Hoeft B, Linseisen J, Beckmann L, Müller-Decker K, Canzian F, Hüsing A, Kaaks R, Vogel U, Jakobsen MU, Overvad K, Hansen RD, Knüppel S, Boeing H, Trichopoulou A, Koumantaki Y, Trichopoulos D, Berrino F, Palli D, Panico S, Tumino R, Bueno-de-Mesquita HB, van Duijnhoven FJ, van Gils CH, Peeters PH, Dumeaux V, Lund E, Huerta Castaño JM, Muñoz X, Rodriguez L, Barricarte A, Manjer J, Jirström K, Van Guelpen B, Hallmans G, Spencer EA, Crowe FL, Khaw KT, Wareham N, Morois S, Boutron-Ruault MC, Clavel-Chapelon F, Chajes V, Jenab M, Boffetta P, Vineis P, Mouw T, Norat T, Riboli E, Nieters A.

Carcinogenesis. 2010 Mar;31(3):466-72. doi: 10.1093/carcin/bgp325. Epub 2009 Dec 30.

PMID:
20042636
21.

Towards a more functional concept of causality in cancer research.

Lund E, Dumeaux V.

Int J Mol Epidemiol Genet. 2010 Mar 15;1(2):124-33.

22.

Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition.

Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Fournier A, Chabbert-Buffet N, Boeing H, Schütze M, Trichopoulou A, Trichopoulos D, Lagiou P, Palli D, Krogh V, Tumino R, Vineis P, Mattiello A, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Dumeaux V, Redondo ML, Duell E, Sanchez-Cantalejo E, Arriola L, Chirlaque MD, Ardanaz E, Manjer J, Borgquist S, Lukanova A, Lundin E, Khaw KT, Wareham N, Key T, Chajes V, Rinaldi S, Slimani N, Mouw T, Gallo V, Riboli E.

Int J Cancer. 2010 Jul 15;127(2):442-51. doi: 10.1002/ijc.25050.

23.

Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.

Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, Boeing H, Pischon T, Panico S, Agnoli C, Palli D, Tumino R, Vineis P, Peeters PH, van Gils CH, Bueno-de-Mesquita BH, Vrieling A, Allen NE, Roddam A, Bingham S, Khaw KT, Manjer J, Borgquist S, Dumeaux V, Torhild Gram I, Lund E, Trichopoulou A, Makrygiannis G, Benetou V, Molina E, Donate Suárez I, Barricarte Gurrea A, Gonzalez CA, Tormo MJ, Altzibar JM, Olsen A, Tjonneland A, Grønbaek H, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Slimani N, Boffetta P, Jenab M, Riboli E, Kaaks R.

Int J Cancer. 2010 Apr 1;126(7):1702-15. doi: 10.1002/ijc.24927.

24.

Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.

Lönneborg A, Aarøe J, Dumeaux V, Børresen-Dale AL.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1115-23. doi: 10.1586/era.09.31. Review.

PMID:
19671031
25.

Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors.

Landmark-Høyvik H, Reinertsen KV, Loge JH, Fosså SD, Børresen-Dale AL, Dumeaux V.

Pharmacogenomics J. 2009 Oct;9(5):333-40. doi: 10.1038/tpj.2009.27. Epub 2009 Jun 23.

PMID:
19546881
26.

Exploring the human genome with functional maps.

Huttenhower C, Haley EM, Hibbs MA, Dumeaux V, Barrett DR, Coller HA, Troyanskaya OG.

Genome Res. 2009 Jun;19(6):1093-106. doi: 10.1101/gr.082214.108. Epub 2009 Feb 26.

27.

Aneuploidy prediction and tumor classification with heterogeneous hidden conditional random fields.

Barutcuoglu Z, Airoldi EM, Dumeaux V, Schapire RE, Troyanskaya OG.

Bioinformatics. 2009 May 15;25(10):1307-13. doi: 10.1093/bioinformatics/btn585. Epub 2008 Dec 3.

28.

Systems epidemiology in cancer.

Lund E, Dumeaux V.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2954-7. doi: 10.1158/1055-9965.EPI-08-0519.

29.

Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study.

Dumeaux V, Børresen-Dale AL, Frantzen JO, Kumle M, Kristensen VN, Lund E.

Breast Cancer Res. 2008;10(1):R13. doi: 10.1186/bcr1859. Epub 2008 Feb 13.

30.

Comparison of globin RNA processing methods for genome-wide transcriptome analysis from whole blood.

Dumeaux V, Lund E, Børresen-Dale AL.

Biomark Med. 2008 Feb;2(1):11-21. doi: 10.2217/17520363.2.1.11.

PMID:
20477359
31.

Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.

Waaseth M, Bakken K, Dumeaux V, Olsen KS, Rylander C, Figenschau Y, Lund E.

BMC Womens Health. 2008 Jan 14;8:1. doi: 10.1186/1472-6874-8-1.

32.

Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft.

Lund E, Dumeaux V, Braaten T, Hjartåker A, Engeset D, Skeie G, Kumle M.

Int J Epidemiol. 2008 Feb;37(1):36-41. Epub 2007 Jul 20. Review. No abstract available.

PMID:
17644530
33.

Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.

Lund E, Bakken K, Dumeaux V, Andersen V, Kumle M.

Int J Cancer. 2007 Aug 1;121(3):645-8.

34.

Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy.

Dumeaux V, Johansen J, Børresen-Dale AL, Lund E.

Mol Cancer Ther. 2006 Apr;5(4):868-76.

35.

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.

Kringen P, Wang Y, Dumeaux V, Nesland JM, Kristensen G, Borresen-Dale AL, Dorum A.

BMC Cancer. 2005 Oct 17;5:134.

36.

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

Dumeaux V, Fournier A, Lund E, Clavel-Chapelon F.

Cancer Causes Control. 2005 Jun;16(5):537-44.

37.

Use of oral contraceptives, alcohol, and risk for invasive breast cancer.

Dumeaux V, Lund E, Hjartåker A.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1302-7.

38.

Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study.

Dumeaux V, Alsaker E, Lund E.

Int J Cancer. 2003 Jul 20;105(6):844-50.

Supplemental Content

Loading ...
Support Center